Photo of Veerle Geurts taken from www.avl.nl
Jun 30, 2024, 16:30
Veerle Geurts: Excellent outcome without chemotherapy for TNBC and high TILs
Veerle Geurts, PhD Candidate at The Netherlands Cancer Institute, shared on LinkedIn:
“Patients with stage I triple negative breast cancer and high TILs have excellent outcome without chemotherapy!
Excited to share our full publication, out now in JAMA oncology.
Thanks to all coauthors!”
Additional information.
Source: Veerle Geurts/LinkedIn
Angela DeMichele
Antonio C. Wolff
Breast Cancer
cancer
chemotherapy
Gabe S. Sonke
Hugo M. Horlings
JAMA Oncology
Marleen Ko
Matthew P. Goetz
MD
Michail ignatiadis
Natalie Klar
OncoDaily
Oncology
Roberto A. Leon-Ferre
Roberto Salgado
Sabine C. Linn
Sabine Siesling
Sara Balduzzi
Sherene Loi
Stefan Michiels
Sunil S. Badve
Sylvia Adams
Tessa G. Steenbruggen
The Netherlands Cancer Institute
TILs
Veerle Geurts
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 22, 2024, 14:46
Oct 22, 2024, 14:34
Oct 22, 2024, 14:23